Center for Workforce Health and Performance report connects clinical progression of type 2 diabetes to work outcomes


Report includes suggestions for achieving better employee health and work-related outcomes

SAN FRANCISCO, Oct. 09, 2018 (GLOBE NEWSWIRE) -- The Center for Workforce Health and Performance (CWHP) today announced the availability of Population Health to Personalized Medicine: Connecting Disease Indicators to Work Outcomes-Type 2 Diabetes. CWHP is a leading provider of research reports, educational resources, and evidence-based data sources on developing and maintaining a healthy and high-performing workforce.

The report details the common clinical progression of a targeted disease linked to indicators, interventions, work outcomes, and employer role. Disease indicators are connected to a variety of work outcomes, including absence, job performance, work disability, and permanent departure from the workforce. Additionally, the report emphasizes the equal importance of diagnosis and treatment by connecting population health indicators to personalized medicine. The report summarizes a selection of research-based evidence on improving diagnosis and treatment for better health and work-related outcomes. The report is authored by CWHP President and CEO Kimberly Jinnett, MSPH, PhD.

“More than a third of Americans are estimated to have pre-diabetes, yet 90% do not know they have it. Having pre-diabetes is correlated with a higher risk of developing type 2 diabetes and cardiovascular complications. Type 2 diabetes is the most common form of diabetes. According to the Centers for Disease Control and Prevention (CDC), type 2 diabetes accounts for approximately 90-95% of all diagnosed diabetes in adults. Fortunately, while type 2 diabetes is increasingly prevalent, it is also largely preventable and, for those who develop it, highly treatable with a patient-centered approach. This is good news for employers, who, armed with the necessary information, may be instrumental in preventing the progression of diabetes, and its impact on their workforce’s health and performance,” said Dr. Jinnett.

In addition to the report on diabetes, the Population Health to Personalized Medicine series will include reports on depression, cancer, pain, and multi-morbidity. This series is part of the initiative Patient-Centered Outcomes Research (PCOR) Dissemination at Work: How Employers Use Evidence to Make Employee Health Investment Decisions.

Population Health to Personalized Medicine: Connecting Disease Indicators to Work Outcomes-Type 2 Diabetes may be accessed here.

About the Patient-Centered Outcomes Research Dissemination at Work Series
The PCOR Dissemination at Work series is partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (#2970-CWHP). The views presented in this series are solely the responsibility of the author(s) and do not necessarily represent the views of PCORI, its Board of Governors, or its Methodology Committee.

About The Center for Workforce Health and Performance (CWHP)
The Center for Workforce Health and Performance is an information hub for research reports, educational resources, and a variety of evidence-based data sources on developing and maintaining a healthy and high-performing workforce. A leading provider of workforce health and performance improvement materials disseminated through scientific and educational channels, CWHP contributes to the adoption of evidence-based policies and practices that support a healthier, happier, and higher-performing workforce, which in turn contributes to a healthier economy, and, healthier and more productive communities. Additional information may be found at www.tcwhp.org.

Media Contact
Robin Schoen
215.595.7542
rschoen@robinschoenpr.com